학술논문
Risk of multiple drug interactions potentially linked to safety in patients receiving pangenotypic direct-acting antivirals for the treatment of Hepatitis C
Document Type
Abstract
Author
Source
In Annals of Hepatology December 2022 27 Supplement 3
Subject
Language
ISSN
1665-2681